Research output per year
Research output per year
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Abstract 5611: LAG-3 PET imaging in patients with cancer before immune checkpoint inhibitor therapy
van de Donk, P., Smit, L., van Sluis, J., Timens, W., Brouwers, A., Lub-de Hooge, M., Elias, S. G., Gietema, J. A., van Winkel, C., Wang, J., Giurleo, J., Uldrick, T., Cheung, H. K., Jalving, M., Oosting, S. F., Knapen, D., de Groot, D. J. & de Vries, E. G. E., 1-Apr-2023.Research output: Contribution to conference › Abstract › Professional
Open Access -
A Survival Tree of Advanced Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors
van Not, O. J., Wind, T. T., Ismail, R. K., Bhattacharya, A., Jalving, M., Blank, C. U., Aarts, M. J. B., van den Berkmortel, F. W. P. J., Boers-Sonderen, M. J., van den Eertwegh, A. J. M., de Groot, J. W. B., Haanen, J. B., Kapiteijn, E., Bloem, M., Piersma, D., van Rijn, R. S., Stevense-den Boer, M., van der Veldt, A. A. M., Vreugdenhil, G., Wouters, M. W. J. M., & 4 others, 26-May-2023, In: Cancers. 15, 11, 12 p., 2922.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile9 Downloads (Pure) -
Cinova: a phase II study of CPC634 (nanoparticulate docetaxel) in patients with platinum resistant recurrent ovarian cancer
Boere, I., Vergote, I., Hanssen, R., Jalving, M., Gennigens, C., Ottevanger, P., van de Wouw, Y. J., Rijcken, C. J. F., Mathijssen, R. H. J. & Ledermann, J., 17-Apr-2023, (E-pub ahead of print) In: International Journal of Gynecological Cancer. 82 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Correction: Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer
de Heer, E. C., Zois, C. E., Bridges, E., van der Vegt, B., Sheldon, H., Veldman, W. A., Zwager, M. C., van der Sluis, T., Haider, S., Morita, T., Baba, O., Schröder, C. P., de Jong, S., Harris, A. L. & Jalving, M., 28-Aug-2023, In: Journal of experimental & clinical cancer research. 42, 1 p., 220.Research output: Contribution to journal › Erratum
Open AccessFile1 Downloads (Pure) -
Factors associated with long-term antibody response after COVID-19 vaccination in patients treated with systemic treatment for solid tumors
Oosting, S. F., van der Veldt, A. A. M., Fehrmann, R. S. N., Bhattacharya, A., van Binnendijk, R. S., GeurtsvanKessel, C. H., Dingemans, A-M. C., Smit, E. F., Hiltermann, T. J. N., den Hartog, G., Jalving, M., Westphal, T. T., de Wilt, F., Ernst, S. M., Boerma, A., van Zijl, L., Rimmelzwaan, G. F., Kvistborg, P., van Els, C. A. C. M., Rots, N. Y., & 3 others, Aug-2023, In: ESMO Open. 8, 4, 3 p., 101599.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile4 Downloads (Pure)
Activities
-
ESMO climate change task force (External organisation)
Hilde Jalving (Chair)
1-Jan-2023 → …Activity: Membership › Professional
-
Onderzoek bij de medische oncologie
Hilde Jalving (Invited speaker)
20-Jan-2023Activity: Talk and presentation › Professional or public presentation › Professional
-
Onvoorspelbare levensverwachting
Hilde Jalving (Invited speaker)
27-Mar-2023Activity: Talk and presentation › Professional or public presentation › Professional
-
Behandeling melanoom: van confectie naar maatpak
Lukas Been (Invited speaker) & Hilde Jalving (Invited speaker)
9-Jun-2023Activity: Talk and presentation › Professional or public presentation › Professional
-
Update systeemtherapie niet-melanoom huidkanker
Hilde Jalving (Invited speaker)
8-Dec-2022Activity: Talk and presentation › Professional or public presentation › Professional
Press/Media
-
“Green” prescribing may limit the environmental impact of oncology
05/06/2023
1 Media contribution
Press/Media: Expert Comment › Professional
-
MEDtalks E-learning; Zeldzame melanomen en huidtumoren
06/02/2023
1 Media contribution
Press/Media: Expert Comment › Professional